Correlation Between Revolution Medicines and Edgewise Therapeutics
Can any of the company-specific risk be diversified away by investing in both Revolution Medicines and Edgewise Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Revolution Medicines and Edgewise Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Revolution Medicines and Edgewise Therapeutics, you can compare the effects of market volatilities on Revolution Medicines and Edgewise Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Revolution Medicines with a short position of Edgewise Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Revolution Medicines and Edgewise Therapeutics.
Diversification Opportunities for Revolution Medicines and Edgewise Therapeutics
0.8 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Revolution and Edgewise is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding Revolution Medicines and Edgewise Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Edgewise Therapeutics and Revolution Medicines is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Revolution Medicines are associated (or correlated) with Edgewise Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Edgewise Therapeutics has no effect on the direction of Revolution Medicines i.e., Revolution Medicines and Edgewise Therapeutics go up and down completely randomly.
Pair Corralation between Revolution Medicines and Edgewise Therapeutics
Given the investment horizon of 90 days Revolution Medicines is expected to generate 1.1 times more return on investment than Edgewise Therapeutics. However, Revolution Medicines is 1.1 times more volatile than Edgewise Therapeutics. It trades about 0.27 of its potential returns per unit of risk. Edgewise Therapeutics is currently generating about -0.14 per unit of risk. If you would invest 4,851 in Revolution Medicines on August 24, 2024 and sell it today you would earn a total of 827.00 from holding Revolution Medicines or generate 17.05% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Revolution Medicines vs. Edgewise Therapeutics
Performance |
| Timeline |
| Revolution Medicines |
| Edgewise Therapeutics |
Revolution Medicines and Edgewise Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Revolution Medicines and Edgewise Therapeutics
The main advantage of trading using opposite Revolution Medicines and Edgewise Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Revolution Medicines position performs unexpectedly, Edgewise Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edgewise Therapeutics will offset losses from the drop in Edgewise Therapeutics' long position.| Revolution Medicines vs. Lyra Therapeutics | Revolution Medicines vs. Hookipa Pharma | Revolution Medicines vs. Cingulate Warrants | Revolution Medicines vs. SAB Biotherapeutics |
| Edgewise Therapeutics vs. Lyra Therapeutics | Edgewise Therapeutics vs. Hookipa Pharma | Edgewise Therapeutics vs. Cingulate Warrants | Edgewise Therapeutics vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |